ANTHELZA

This brand name is authorized in Nigeria.

Active ingredients

The drug ANTHELZA contains one active pharmaceutical ingredient (API):

1	Albendazole UNII F4216019LN - ALBENDAZOLE
	Albendazole causes degenerative alterations in the tegument and intestinal cells of the worm by binding to the colchicine-sensitive site of tubulin, thus inhibiting its polymerization or assembly into microtubules.
	Read more about Albendazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7601	Tablet	ANTHELZA TABLET TAB 400 mg 1X1X20	30 RNW-PP-266654 ANTHELZA TABLET ALBENDAZOLE USP 400MG Albendazole USP (Micronized) 400mg, Maize Starch, Colloidal silicon dioxide, Tween -80 Polyvinyl pyrolidone k-30, Purified Talc, Cross Povidone, Flavour-Pineapple STR DM, Maize starch Aspartame, Kyron- T- 314, Sodium Lauryl Sulphate, Sodium bicarbonate, Magnesium stearate, Colloidal silicon dioxide B4-7601 Drugs Imported Products 1120 Prescription Only Medicine (POM) 10/25/2022 DAITECH PHARMACEUTICALS LTD, BLOCK B4, COUNTESS COURT, MABUSHI, ABUJA, FCT, NIGERIA 92919163 daitechpharma@gmail.com M/S MCW HEALTHCARE(P) LTD, 286, 287-A, 287-B, SECTOR-E, INDUSTRIAL AREA, SANWER ROAD, INDORE (M.P), INDIA, India	07/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P02CA03	Albendazole	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CA Benzimidazole derivatives
Discover more medicines within P02CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7601